deltatrials
Completed PHASE1 INTERVENTIONAL 10-arm NCT01296451

Study of a New MVA Vaccine for Hepatitis C Virus

A Phase I Study to Assess the Safety and Immunogenicity of AdCh3NSmut and MVA-NSmut in Healthy Volunteers and Patients With Hepatitis C Virus Infection

Sponsor: Oxford University Hospitals NHS Trust

Conditions Hepatitis C Infection
Interventions AdCh3NSmut AdCh3NSmut1 MVA-NSmut
Updated 5 times since 2017 Last updated: Apr 24, 2016 Started: Dec 31, 2010 Primary completion: Jan 31, 2016 Completion: Jan 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Hepatitis C Infection, this trial is completed. The trial is conducted by Oxford University Hospitals NHS Trust and has accumulated 5 data snapshots since 2010. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 21 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Oxford University Hospitals NHS Trust
  • ReiThera Srl
  • University Hospital Birmingham
  • University of Oxford
Data source: ReiThera Srl

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations